198 related articles for article (PubMed ID: 36271425)
1. Concomitant elevated serum levels of tenascin, MMP-9 and YKL-40, suggest ongoing remodeling of the heart up to 3 months after cardiac surgery after normalization of the revascularization markers.
Liu D; Ghani D; Wain J; Szeto WY; Laudanski K
Eur J Med Res; 2022 Oct; 27(1):208. PubMed ID: 36271425
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Dynamic of Leptin and Fibroblast Growth Factor 21 in 123 Patients Recovering from Cardiac Surgery.
Liu D; Ghani D; Szeto WY; Laudanski K
Med Sci Monit; 2022 Sep; 28():e937652. PubMed ID: 36171690
[TBL] [Abstract][Full Text] [Related]
3. A decline of protective apolipoprotein J and complement factor H concomitant with increase in C5a 3 months after cardiac surgery-Evidence of long-term complement perturbations.
Laudanski K; Liu D; Gullipalli D; Song WC; Okeke T; Szeto WY
Front Cardiovasc Med; 2022; 9():983617. PubMed ID: 36606279
[TBL] [Abstract][Full Text] [Related]
4. Persistent Depletion of Neuroprotective Factors Accompanies Neuroinflammatory, Neurodegenerative, and Vascular Remodeling Spectra in Serum Three Months after Non-Emergent Cardiac Surgery.
Laudanski K; Liu D; Okeke T; Restrepo M; Szeto WY
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289630
[TBL] [Abstract][Full Text] [Related]
5. Serum level of total histone 3, H3K4me3, and H3K27ac after non-emergent cardiac surgery suggests the persistence of smoldering inflammation at 3 months in an adult population.
Laudanski K; Liu D; Hajj J; Ghani D; Szeto WY
Clin Epigenetics; 2022 Sep; 14(1):112. PubMed ID: 36068552
[TBL] [Abstract][Full Text] [Related]
6. Whole Blood Reactivity to Viral and Bacterial Pathogens after Non-Emergent Cardiac Surgery during the Acute and Convalescence Periods Demonstrates a Distinctive Profile of Cytokines Production Compared to the Preoperative Baseline in Cohort of 108 Patients, Suggesting Immunological Reprogramming during the 28 Days Traditionally Recognized as the Post-Surgical Recovery Period.
Laudanski K; Liu D; Karnatovskaia L; Devang S; Mathew A; Szeto WY
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275389
[TBL] [Abstract][Full Text] [Related]
7. Immunological Signatures in Blood and Urine in 80 Individuals Hospitalized during the Initial Phase of COVID-19 Pandemic with Quantified Nicotine Exposure.
Laudanski K; Mahmoud MA; Ahmed AS; Susztak K; Mathew A; Chen J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612525
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors.
Pedersen SJ; Hetland ML; Sørensen IJ; Ostergaard M; Nielsen HJ; Johansen JS
Clin Rheumatol; 2010 Nov; 29(11):1301-9. PubMed ID: 20640910
[TBL] [Abstract][Full Text] [Related]
9. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy.
Guha D; Misra V; Yin J; Horiguchi M; Uno H; Gabuzda D
AIDS; 2023 Nov; 37(14):2137-2147. PubMed ID: 37503603
[TBL] [Abstract][Full Text] [Related]
10. The impact of apical periodontitis, non-surgical root canal retreatment and periapical surgery on serum inflammatory biomarkers.
Bakhsh A; Moyes D; Proctor G; Mannocci F; Niazi SA
Int Endod J; 2022 Sep; 55(9):923-937. PubMed ID: 35707939
[TBL] [Abstract][Full Text] [Related]
11. A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis.
van Sleen Y; Jiemy WF; Pringle S; van der Geest KSM; Abdulahad WH; Sandovici M; Brouwer E; Heeringa P; Boots AMH
Arthritis Rheumatol; 2021 Dec; 73(12):2327-2337. PubMed ID: 34105308
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Glycoprotein YKL-40 Is Elevated after Coronary Artery Bypass Surgery and Correlates with Leukocyte Chemotaxis and Myocardial Injury, a Pilot Study.
Laurikka A; Vuolteenaho K; Toikkanen V; Rinne T; Leppänen T; Hämäläinen M; Tarkka M; Laurikka J; Moilanen E
Cells; 2022 Oct; 11(21):. PubMed ID: 36359773
[TBL] [Abstract][Full Text] [Related]
13. Combined plasma C-reactive protein, interleukin 6 and YKL-40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer.
Videmark AN; Christensen IJ; Feltoft CL; Villadsen M; Borg FH; Jørgensen BM; Bojesen SE; Kistorp C; Ugleholdt R; Johansen JS
Cancer Med; 2023 Mar; 12(6):6675-6688. PubMed ID: 36440611
[TBL] [Abstract][Full Text] [Related]
14. YKL-40 as a new biomarker of disease activity in Takayasu arteritis.
Sun Y; Kong X; Wu S; Ma L; Yan Y; Lv P; Jiang L
Int J Cardiol; 2019 Oct; 293():231-237. PubMed ID: 31303395
[TBL] [Abstract][Full Text] [Related]
15. YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome.
Kastelijn EA; van Moorsel CH; Ruven HJ; Korthagen NM; Kwakkel-van Erp JM; van de Graaf EA; Zanen P; van Kessel DA; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Mar; 30(1):28-35. PubMed ID: 24003532
[TBL] [Abstract][Full Text] [Related]
16. Serum markers in early-stage and locally advanced melanoma.
Lugowska I; Kowalska M; Fuksiewicz M; Kotowicz B; Mierzejewska E; Koseła-Paterczyk H; Szamotulska K; Rutkowski P
Tumour Biol; 2015 Nov; 36(11):8277-85. PubMed ID: 26002577
[TBL] [Abstract][Full Text] [Related]
17. Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.
Lorenz G; Schmalenberg M; Kemmner S; Haller B; Steubl D; Pham D; Schreiegg A; Bachmann Q; Schmidt A; Haderer S; Huber M; Angermann S; Günthner R; Braunisch M; Hauser C; Reichelt AL; Matschkal J; Suttmann Y; Moog P; Stock K; Küchle C; Thürmel K; Renders L; Bauer A; Baumann M; Heemann U; Luppa PB; Schmaderer C
Kidney Int; 2018 Jan; 93(1):221-230. PubMed ID: 28941940
[TBL] [Abstract][Full Text] [Related]
18. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality.
Laucyte-Cibulskiene A; Ward LJ; Ebert T; Tosti G; Tucci C; Hernandez L; Kautzky-Willer A; Herrero MT; Norris CM; Pilote L; Söderberg M; Brismar TB; Ripsweden J; Stenvinkel P; Raparelli V; Kublickiene K;
Biol Sex Differ; 2021 Sep; 12(1):50. PubMed ID: 34526107
[TBL] [Abstract][Full Text] [Related]
19. Serum YKL-40 positively correlates with MMP-9 and CRP in patients with acute ST segment elevation myocardial infarction following emergency treatment.
Tan Y; Ji X; Mo Z; Zhou Y
Medicine (Baltimore); 2019 Nov; 98(47):e17950. PubMed ID: 31764795
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.
Li J; Lin J; Pan Y; Wang M; Meng X; Li H; Wang Y; Zhao X; Qin H; Liu L; Wang Y;
J Neuroinflammation; 2022 Jun; 19(1):131. PubMed ID: 35761288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
